Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivatives

Carbohydrate Polymers

Volumn 78, Issue 4, 2009, Pages 869-872

  Yoon, Na Young ^a   Ngo, Dai Nghiep ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Acetylcholinesterase; Chitooligosaccharide derivatives; Diethylaminoethyl chitooligosaccharide; Dimethylaminoethyl chitooligosaccharide

Indexed keywords

ACETYLCHOLINESTERASE; ALZHEIMER'S DISEASE; BUTYRYLCHOLINESTERASE; CHITOOLIGOSACCHARIDE DERIVATIVES; CHITOOLIGOSACCHARIDES; DIETHYLAMINOETHYL; DIETHYLAMINOETHYL CHITOOLIGOSACCHARIDE; DIMETHYLAMINOETHYL CHITOOLIGOSACCHARIDE; INHIBITORY ACTIVITY; INHIBITORY PATTERNS; LINEWEAVER-BURK PLOTS; SPECTROSCOPIC TECHNIQUE; SUBSTITUTION GROUPS;

COMPETITION;

ACOUSTIC EMISSIONS;

EID: 69749111211     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2009.07.004     Document Type: Article

References (30)

1. Adams R.L., Crai P.L., and Parsons O.A. Neuropsychology of dementia. Neurologic Clinics 4 (1984) 387-405
2. Aisen P.S., and Davis K.L. The search for disease-modifying treatment for Alzheimer's disease. Neurology 48 (1997) 35-41
3. Brenner G.M. Pharmacology. (pp. 277-318) (2000), W.B. Saunders Company, Philadelphia
4. Davies P., and Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2 (1976) 1403
5. Dou J.L., Tan C.Y., Du Y.G., Bai X.F., Wang K.Y., and Ma X.J. Effects of chitooligosaccharides on rabbit neutrophils in vitro. Carbohydrate Polymers 69 (2007) 209-213
6. Ecobicon D.J., and Corneau A.M. Pseudocholinestarase of mammalian plasma: Physiochemical properties and organophosphate inhibition in eleven species. Toxicology and Applied Pharmacology 24 (1973) 29-100
7. Ellman G.L., Courtney D., Andres K.D.V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7 (1961) 88-95
8. Greig N.H., Utsuki T., Yu Q.S., Zhu X., Holloway H.W., Perry T., et al. A new therapeutic target in Alzheimer's disease treatment: Attention to butyrylcholinesterase. Current Medical Research and Opinion 3 (2001) 159-165
9. Higa T. Phenolic substances. In: Scheuer P.J. (Ed). Marine Natural Products, Chemical and Biological Perspectives Vol. 4 (1981), Academic Press, New York 119-123
10. Jann M.W. Preclinical pharmacology of metrifonate. Pharmacotherapy 18 (1998) 55-67
11. Je J.Y., and Kim S.K. Antimicrobial action of novel chitin derivative. Biochimica et Biophysica Acta 1760 (2006) 104-109
12. Je J.Y., Park P.J., and Kim S.K. Free radical scavenging properties of hetero-chitooligosaccharides using an ESR spectroscopy. Food and Chemical Toxicology 42 (2004) 381-387
13. Jeon Y.J., and Kim S.K. Antitumor activity of chitosan oligosaccharides produced in ultrafiltration membrane reactor system. Journal of Microbiology and Biotechnology 12 (2002) 503
14. Jeon Y.J., Park P.J., and Kim S.K. Antimicrobial effect of chitooligosaccharides produced by bioreactor. Carbohydrate Polymers 44 (2001) 71-76
15. Katsura S., Isogai A., Onabe F., and Usuda M. NMR analyses of polysaccharide derivatives containing amine groups. Carbohydrate Polymers 18 (1992) 283-298
16. Kim S.K., Ngo D.N., and Rajapakse N. Therapeutic prospectives of chitin, chitosan and their derivatives. Journal of Chitin Chitosan 11 (2006) 1-10
17. Lee S.H., Park J.S., Kim S.K., Ahn C.B., and Je J.Y. Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Aβ 25-35 in PC12 cells. Bioorganic & Medicinal Chemistry Letter 19 (2009) 860-862
18. Massoulie J., Pezzementi L., Bom S., Krejci E., and Vallette F.M. Molecular and cellular biology of cholinesterases. Progress in Neurobiology 41 (1993) 31-91
19. Melzer D. New drug treatment for Alzheimer's disease: Lessons for healthcare policy. British Medical Journal 316 (1998) 762-764
20. Mesulam M., Guillozet A., Shaw P., and Quinn B. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiology of Disease 9 (2002) 88-93
21. Milatovic D., and Dettbarn W.D. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat. Toxicology and Applied Pharmacology 136 (1996) 20-28
22. Millard C.B., and Broomfield C.A. Anticholinesterases: Medical applications of neurochemical principles. Journal of Neurochemistry 64 (1995) 1909-1918
23. Ngo D.N., Qian Z.J., Je J.Y., Kim M.M., and Kim S.K. Aminoethyl chitooligosaccharides inhibit the activity of angiotensin converting enzyme. Precess Biochemistry 43 (2008) 119-123
24. Schetinger M.R.C., Porto N.M., Moretto M.B., Morsch V.M., Rocha J.B.T., Vieira V., et al. New benzodiazepines alter acetylcholinesterase and ATPase activities. Neurochemical Research 25 (2000) 949-955
25. Schulz V. Ginkgo extract or cholinesterase inhibitors in patients with dementia: What clinical trials and guidelines fail to consider. Phytomedicine 10 (2003) 74-79
26. Small G.W., Rabins P.V., Barry P.P., Buckholts N.S., Dekosky S.T., Ferris S.H., et al. Diagnosis and treatment of Alzheimer disease and related disorders. Journal of the American Medical Association 278 (1997) 1363-1371
27. Tokoro A., Tatewaki N., Suzuki K., Mikimi T., Suzuki S., and Suzuki M. Growth-inhibitory effect of hexa-Nacetylchitohexaose and chitohexaose Meth-a solid tumor. Chemical & Pharmaceutical Bulletin 36 (1988) 784-790
28. Weinstock M., and Groner E. Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity. Chemico-Biological Interactions 175 (2008) 216-221
29. Whitehouse P.J., Price D.L., Struble G.R., Clarke A.W., Coyle J.T., and DeLong M.R. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 15 (1982) 1237-1239
30. Yu S.Q., Utsuki H.W., Brossi T., and Greig A.N.H. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. Journal of Medicinal Chemistry 42 (1999) 1855-1861